MktsMarkets

Phathom Pharmaceuticals, Inc.
NASDAQ: PHATKey statistics
PHAT News
Stories mentioning PHAT from around the web — every one is an open thread, so give it a like or add your take.
Loading news…
Financial statements
As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.
| Line item | Q1 '26Mar 31 | Q4 '25Dec 31 | Q3 '25Sep 30 | Q2 '25Jun 30 | Q1 '25Mar 31 | Q4 '24Dec 31 | Q3 '24Sep 30 | Q2 '24Jun 30 |
|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||
| Revenue | 58,301 | 57,584 | 49,504 | 39,503 | 28,519 | 29,664 | 16,352 | 7,324 |
| Cost of Goods Sold | 11,996 | 7,647 | 6,190 | 5,038 | 3,724 | 3,815 | 2,356 | 1,376 |
| Gross Profit | 46,305 | 49,937 | 43,314 | 34,465 | 24,795 | 25,849 | 13,996 | 5,948 |
| Operating Expenses | ||||||||
| Research & Development | 7,771 | 7,493 | 7,027 | 9,076 | 9,184 | 8,583 | 8,693 | 7,376 |
| Sales General & Admin | 54,011 | 48,372 | 51,558 | 85,313 | 94,474 | 76,683 | 76,099 | 75,872 |
| Total Operating Expenses | 61,782 | 55,865 | 58,585 | 94,389 | 103,658 | 85,266 | 84,792 | 83,248 |
| Operating Income (Loss) | (15,477) | (5,928) | (15,271) | (59,924) | (78,863) | (59,417) | (70,796) | (77,300) |
| Interest Income | 1,736 | 1,204 | 1,413 | 1,787 | 2,640 | 3,510 | 3,711 | 3,624 |
| Interest Expense | 17,764 | |||||||
| Other Expense | (831.00) | (6.00) | (7.00) | (155.00) | (22.00) | 49.00 | (8.00) | (6.00) |
| Pretax Income | ||||||||
| Tax Provision | ||||||||
| Net Income (Loss) | (30,369) | (21,148) | (29,973) | (75,810) | (94,316) | (74,451) | (85,577) | (91,446) |
| Earnings Per Share (Basic) | (0.37) | (0.29) | (0.41) | (1.05) | (1.31) | (1.18) | (1.32) | (1.56) |
| Earnings Per Share (Diluted) | (0.37) | (0.29) | (0.41) | (1.05) | (1.31) | (1.18) | (1.32) | (1.56) |
| Weighted Average Shares Outstanding (Basic) | 82,051 | 72,919 | 73,396 | 72,466 | 71,969 | 63,176 | 64,628 | 58,558 |
| Weighted Average Shares Outstanding (Diluted) | 82,051 | 72,919 | 73,396 | 72,466 | 71,969 | 63,176 | 64,628 | 58,558 |
Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.
About PHAT
Phathom Pharmaceuticals, Inc. (NASDAQ: PHAT) is a stock listed on the Nasdaq Stock Market under the ticker symbol PHAT. It last traded at $5.99 (Nov 16, 2026, 1:05 PM ET), down 1.2% on the day. That gives Phathom Pharmaceuticals a market capitalisation of $492.6M.
Over the past 52 weeks PHAT has traded between $5.01 and $18.31.
Revenue for the quarter ended Mar 31, 2026 was $58.3M; a net loss of $30.4M. Revenue was up 104% from $28.5M in the quarter ended Mar 31, 2025.
| Quarter ended | Revenue | Net income | Margin |
|---|---|---|---|
| Mar 31, 2026 | $58.3M | -$30.4M | -52.1% |
| Dec 31, 2025 | $57.6M | -$21.1M | -36.7% |
| Sep 30, 2025 | $49.5M | -$30.0M | -60.5% |
| Jun 30, 2025 | $39.5M | -$75.8M | -191.9% |
From Phathom Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.
Take a break — play a market game
Seven free games built around the markets. No download, no sign-up: they run right here in your browser.
Latest News
Market news from around the web — every story is an open thread, so give it a like or add your take.
Loading news…